ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
YS Biopharma Company Ltd

YS Biopharma Company Ltd (YS)

1.02
0.00
(0.00%)
終了 1月30日 6:00AM
0.00
0.00
(0.00%)
取引時間後: -

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
1.02
買値
1.02
売値
1.07
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
時価総額
前日終値
1.02
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
93,058,200
配当利回り
-
PER
-0.58
1 株当たり利益 (EPS)
-4.66
歳入
573.42M
純利益
-433.47M

YS Biopharma Company Ltd について

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is als... YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Beijing, Chn
設立
-

YS 最新ニュース

LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan

GAITHERSBURG, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) (“LakeShore Biopharma” or the “Company”), a global leader in the discovery, development...

YS Biopharma Announces Name Change to LakeShore Biopharma

YS Biopharma Announces Name Change to LakeShore Biopharma PR Newswire GAITHERSBURG, Md., May 24, 2024 GAITHERSBURG, Md., May 24, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS...

YS Biopharma Announces Results of Extraordinary General Meeting

YS Biopharma Announces Results of Extraordinary General Meeting PR Newswire GAITHERSBURG, Md., May 21, 2024 GAITHERSBURG, Md., May 21, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS...

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer

YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer PR Newswire GAITHERSBURG, Md., May 7, 2024 GAITHERSBURG, Md...

YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule PR Newswire GAITHERSBURG, Md., April 29, 2024 GAITHERSBURG, Md., April 29, 2024...

YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024

YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024 PR Newswire GAITHERSBURG, Md., April 19, 2024 GAITHERSBURG, Md., April 19, 2024 /PRNewswire/ -- YS...

YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine

YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine PR Newswire GAITHERSBURG, Md., April 18, 2024 GAITHERSBURG, Md., April 18, 2024 /PRNewswire/...

YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024

YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024 PR Newswire GAITHERSBURG, Md., April 16, 2024 GAITHERSBURG, Md., April 16, 2024 /PRNewswire/ -- YS...

YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine

YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine PR Newswire GAITHERSBURG, Md., April 9, 2024 GAITHERSBURG, Md., April 9, 2024 /PRNewswire/...

YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility

YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility PR Newswire GAITHERSBURG, Md., April 3, 2024 GAITHERSBURG, Md., April 3, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq:...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

YS - Frequently Asked Questions (FAQ)

What is the current YS Biopharma share price?
The current share price of YS Biopharma is US$ 1.02
How many YS Biopharma shares are in issue?
YS Biopharma has 93,058,200 shares in issue
What is the market cap of YS Biopharma?
The market capitalisation of YS Biopharma is USD 94.92M
What is the 1 year trading range for YS Biopharma share price?
YS Biopharma has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of YS Biopharma?
The price to earnings ratio of YS Biopharma is -0.58
What is the cash to sales ratio of YS Biopharma?
The cash to sales ratio of YS Biopharma is 0.44
What is the reporting currency for YS Biopharma?
YS Biopharma reports financial results in CNY
What is the latest annual turnover for YS Biopharma?
The latest annual turnover of YS Biopharma is CNY 573.42M
What is the latest annual profit for YS Biopharma?
The latest annual profit of YS Biopharma is CNY -433.47M
What is the registered address of YS Biopharma?
The registered address for YS Biopharma is BUILDING NO. 2, 38 YONGDA ROAD DAXING BIOMEDICAL INDUSTRY PARK, DAXING DISTRICT, BEIJING
What is the YS Biopharma website address?
The website address for YS Biopharma is www.yishengbio.com.
Which industry sector does YS Biopharma operate in?
YS Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AALAmerican Airlines Group Inc
US$ 17.33
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.435
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.89
(0.00%)
0
AACGATA Creativity Global
US$ 0.8559
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.33
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.435
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.89
(0.00%)
0
AACGATA Creativity Global
US$ 0.8559
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.33
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.435
(0.00%)
0
AADIAadi Bioscience Inc
US$ 2.89
(0.00%)
0
AACGATA Creativity Global
US$ 0.8559
(0.00%)
0

YS Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock